Study group | Time interval in months | Those at risk during interval Nt | Average Number at risk of IDA during interval, Nt* | Number Recovering from IDA during interval, Rt | Lost to Follow-up, Ct | Proportion Recovering from IDA during interval, qt | Among those at risk, proportion surviving during Interval, pt | Survival Probability St |
---|---|---|---|---|---|---|---|---|
SCSB | 0 | 80 | 40 | |||||
1 | 73 | 73 | 7 | 5.39 | 4.39 | 4.39 | ||
2 | 56 | 36 | 16 | 1 | 12.32 | 11.32 | 49.70 | |
3 | 32 | 15.5 | 23 | 1 | 17.71 | 16.71 | 81.51 | |
4 | 9 | 4 | 22 | 1 | 16.94 | 15.94 | 94.42 | |
5 | 4.5 | 9 | 6.93 | 5.93 | 100.00 | |||
6 | 0.00 | 0.00 | 100.00 | |||||
CSB | 0 | 80 | 40 | |||||
1 | 79 | 39 | 1 | |||||
2 | 78 | 39 | 1 | 0.78 | 0.22 | 0.22 | ||
3 | 77 | 38.5 | 1 | 0.77 | 0.23 | 2.05 | ||
4 | 73 | 36 | 3 | 1 | 2.19 | 1.19 | 3.61 | |
5 | 69 | 34.5 | 5 | 3.45 | 2.45 | 4.76 | ||
6 | 59 | 29.5 | 10 | 5.90 | 4.90 | 5.49 | ||
Placebo | 0 | 80 | 40 | |||||
1 | 79 | 39 | 1 | 0.00 | 0.00 | 0.00 | ||
2 | 78 | 38.5 | 1 | 0.00 | 0.00 | 0.00 | ||
3 | 77 | 38 | 1 | 0.00 | 0.00 | 0.00 | ||
4 | 75 | 37 | 1 | 1 | 0.75 | 0.75 | 0.75 | |
5 | 74 | 37 | 1 | 0.00 | 0.00 | 0.75 | ||
6 | 72 | 36 | 1 | 1 | 0.72 | 0.72 | 0.54 |